# Duke Clinical Research Institute

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/duke-clinical-research-institute/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | private university in Durham, North Carolina, USA |
| OpenAlex ID | https://openalex.org/F4320337533 |
| ROR ID | https://ror.org/00py81415 |
| Works | 1,596 |

## Funder papers

- [Empagliflozin after Acute Myocardial Infarction](https://scholariq.org/papers/empagliflozin-after-acute-myocardial-infarction/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial](https://scholariq.org/papers/vericiguat-in-patients-with-chronic-heart-failure-and-reduced-ejection-fraction/)
- [Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery](https://scholariq.org/papers/levosimendan-in-patients-with-reduced-left-ventricular-function-undergoing/)
- [Effect of once‐weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A <i>post hoc</i> analysis of the <scp>EXSCEL</scp> trial](https://scholariq.org/papers/effect-of-once-weekly-exenatide-on-estimated-glomerular-filtration-rate-slope/)
- [Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial](https://scholariq.org/papers/association-between-levosimendan-postoperative-aki-and-mortality-in-cardiac/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.